Phenobarbital 16.2mg, hyoscyamine sulfate 0.1037mg, atropine sulfate 0.0194mg, scopolamine HBr 0.0065mg. Glaucoma. Porphyria. Unstable cardiovascular status. GI or GU ...

Phenobarbital 16.2mg, hyoscyamine sulfate 0.1037mg, atropine sulfate 0.0194mg, scopolamine HBr 0.0065mg; per 5mL; contains alcohol; grape flavor. <10lb (4.5kg): not ...

RedHill and Concordia entered into an exclusive co-promotion agreement, granting RedHill certain U.S. promotion rights for Donnatal® Donnatal®1, Tablets and Elixir (syrup),is a prescription oral drug ...

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced the signing of an exclusive co-promotion agreement with a subsidiary of Concordia International Corp. (Concordia), an ...

RedHill has initiated commercial activities in the U.S. with its gastrointestinal-focused sales force, promoting two gastrointestinal specialty products, Donnatal ® and EnteraGam ® RedHill`s U.S.

Donnatal®, one of the medical world's most often-prescribed medications used to treat Irritable Bowel Syndrome (IBS), received an important revalidation in a recently-released study presented at the ...

Concordia International Corp., an international specialty pharmaceutical company, has entered into a three-year, co-promotion agreement with RedHill Biopharma Ltd. (RedHill) through which the ...

RedHill expects to initiate U.S. promotion of its two commercially-available gastrointestinal specialty products, Donnatal ® 1 and EnteraGam ® 2, in mid-2017 TEL-AVIV, Israel, April 05, 2017 (GLOBE ...

In 2014, Concordia Healthcare bought Donnatal, a decades-old drug used to treat irritable bowel syndrome. The $265 million deal was a windfall for a company backed by Paul Manning and his PBM Capital ...